.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
Argus Health
Boehringer Ingelheim
Deloitte
QuintilesIMS
Harvard Business School
Cipla
UBS
Federal Trade Commission

Generated: December 18, 2017

DrugPatentWatch Database Preview

Ondansetron hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for ondansetron hydrochloride and what is the scope of ondansetron hydrochloride patent protection?

Ondansetron hydrochloride
is the generic ingredient in six branded drugs marketed by Accord Hlthcare, Apotex Inc, Aurobindo Pharma Ltd, Baxter Hlthcare Corp, Emcure Pharms, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma Farmaceutica, Hospira, Lannett, Luitpold, Mylan Labs Ltd, Pliva Hrvatska Doo, Qilu Pharm Co Ltd, Sagent Pharms, Sandoz Inc, Sun Pharm Inds (in), Teva, West-ward Pharms Int, Wockhardt, Emcure Pharms Ltd, Sun Pharm Inds Ltd, Taro Pharms Ireland, Novartis Pharms Corp, Glaxosmithkline, Amneal Pharms, Apotex, Aurobindo Pharma, Silarx, Taro, Chartwell Molecules, Dr Reddys Labs Ltd, Glenmark Generics, Hikma Intl Pharms, Ipca Labs Ltd, Mylan, Natco Pharma Ltd, and Sandoz, and is included in seventy-two NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-eight drug master file entries for ondansetron hydrochloride. Seventy suppliers are listed for this compound. There are two tentative approvals for this compound.

Pharmacology for ondansetron hydrochloride

Tentative approvals for ONDANSETRON HYDROCHLORIDE

Applicant Application No. Strength Dosage Form
u► SubscribeEQ 2MG BASE/MLINJECTABLE;INJECTION
u► SubscribeEQ 2MG BASE/MLINJECTABLE;INJECTION
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Labs LtdONDANSETRON HYDROCHLORIDE PRESERVATIVE FREEondansetron hydrochlorideINJECTABLE;INJECTION078244-001Apr 23, 2008APRXNoNo► Subscribe► Subscribe► Subscribe
Hikma FarmaceuticaONDANSETRON HYDROCHLORIDE PRESERVATIVE FREEondansetron hydrochlorideINJECTABLE;INJECTION076780-001Dec 26, 2006APRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Labs LtdONDANSETRON HYDROCHLORIDEondansetron hydrochlorideINJECTABLE;INJECTION204906-001Jul 31, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Novartis Pharms CorpZOFRANondansetron hydrochlorideTABLET;ORAL020103-002Dec 31, 1992ABRXYesNo► Subscribe► Subscribe► Subscribe
Qilu Pharm Co LtdONDANSETRON HYDROCHLORIDEondansetron hydrochlorideINJECTABLE;INJECTION203711-001Sep 8, 2014APRXNoNo► Subscribe► Subscribe► Subscribe
ApotexONDANSETRON HYDROCHLORIDEondansetron hydrochlorideTABLET;ORAL077306-002Jun 25, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Glenmark GenericsONDANSETRON HYDROCHLORIDEondansetron hydrochlorideTABLET;ORAL077535-001Jun 25, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms IntONDANSETRON HYDROCHLORIDE PRESERVATIVE FREEondansetron hydrochlorideINJECTABLE;INJECTION077011-001Dec 26, 2006APRXNoNo► Subscribe► Subscribe► Subscribe
Apotex IncONDANSETRON HYDROCHLORIDE PRESERVATIVE FREEondansetron hydrochlorideINJECTABLE;INJECTION077343-001Dec 26, 2006DISCNNoNo► Subscribe► Subscribe► Subscribe
MylanONDANSETRON HYDROCHLORIDEondansetron hydrochlorideTABLET;ORAL076930-004Jun 25, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: ondansetron hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis Pharms CorpZOFRANondansetron hydrochlorideTABLET;ORAL020103-003Aug 27, 1999► Subscribe► Subscribe
Novartis Pharms CorpZOFRANondansetron hydrochlorideSOLUTION;ORAL020605-001Jan 24, 1997► Subscribe► Subscribe
Novartis Pharms CorpZOFRANondansetron hydrochlorideTABLET;ORAL020103-001Dec 31, 1992► Subscribe► Subscribe
Novartis Pharms CorpZOFRANondansetron hydrochlorideTABLET;ORAL020103-003Aug 27, 1999► Subscribe► Subscribe
Novartis Pharms CorpZOFRANondansetron hydrochlorideTABLET;ORAL020103-003Aug 27, 1999► Subscribe► Subscribe
Novartis Pharms CorpZOFRANondansetron hydrochlorideTABLET;ORAL020103-001Dec 31, 1992► Subscribe► Subscribe
GlaxosmithklineZOFRAN AND DEXTROSE IN PLASTIC CONTAINERondansetron hydrochlorideINJECTABLE;INJECTION020403-001Jan 31, 1995► Subscribe► Subscribe
Novartis Pharms CorpZOFRAN PRESERVATIVE FREEondansetron hydrochlorideINJECTABLE;INJECTION020007-003Dec 10, 1993► Subscribe► Subscribe
Novartis Pharms CorpZOFRANondansetron hydrochlorideINJECTABLE;INJECTION020007-001Jan 4, 1991► Subscribe► Subscribe
Novartis Pharms CorpZOFRANondansetron hydrochlorideTABLET;ORAL020103-002Dec 31, 1992► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Citi
Covington
Medtronic
Deloitte
Boehringer Ingelheim
McKesson
Cerilliant
Queensland Health
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot